Ropes & Gray: In Wall Street Journal, Joshua Oyster Discusses Compounded Versions of Weight-Loss Drugs Facing FDA Shortages
June 28, 2024
June 28, 2024
BOSTON, Massachusetts, June 28 -- Ropes and Gray, a law firm, issued the following news on June 26, 2024:
In a Wall Street Journal article that was republished in Yahoo Finance, life sciences regulatory & compliance partner Joshua Oyster discussed the legal risks for compounded forms of weight-loss drugs that use the same active ingredients as FDA-approved drugs that are experiencing shortages.
Joshua notes that once all GLP-1 weight-loss drugs come off the FDA shor . . .
In a Wall Street Journal article that was republished in Yahoo Finance, life sciences regulatory & compliance partner Joshua Oyster discussed the legal risks for compounded forms of weight-loss drugs that use the same active ingredients as FDA-approved drugs that are experiencing shortages.
Joshua notes that once all GLP-1 weight-loss drugs come off the FDA shor . . .